Skip to main content
logo
Auro Laboratories Limited (BOM:530233)
India flag India · Delayed Price · Currency is INR
235.50
-0.30 (-0.13%)
At close: Aug 21, 2026

Auro Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
364.26307.4191.24536.35528.94508.66
Revenue Growth
121.40%60.74%-64.34%1.40%3.99%-6.24%
Gross Profit
292.72244.1198.42266.86168.26173.19
Operating Income
97.2373.9920.3395.7833.1936.08
Net Income
46.8435.3318.3977.9224.4228.45
Earnings Per Share
7.515.672.9512.503.924.56
EPS Growth
377.10%92.14%-76.40%219.03%-14.07%-60.41%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
13.6713.6709.9217.87123.96
Total Debt
633.05633.05450.14262.4464.13137.78
Net Cash (Debt)
-619.38-619.38-450.14-252.52-46.26-13.82
Net Cash Growth
------
Net Cash Per Share
-99.31-99.38-72.22-40.52-7.42-2.22

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-21.1350.2188.0732.81-65.9
Capital Expenditures
--571.39-238.01-356.4-40.74-46.1
Free Cash Flow
--550.26-187.81-168.33-7.93-112
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
80.36%79.41%51.46%49.76%31.81%34.05%
Operating Margin
26.69%24.07%10.63%17.86%6.27%7.09%
Pretax Margin
16.59%15.64%9.83%19.29%6.51%7.62%
Profit Margin
12.86%11.49%9.62%14.53%4.62%5.59%
FCF Margin
--179.01%-98.21%-31.39%-1.50%-22.02%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
31.3646.7578.1512.8913.9521.98
PS Ratio
4.005.377.511.870.641.23